Healthcare -
Biotechnology - NASDAQ - US
$ 11.17
-1.97 %
$ 552 M
Market Cap
-3.04
P/E
KALV - TOTAL EQUITY
Total Equity KALV - KalVista Pharmaceuticals, Inc.
207 M
LAST VALUE
5.65%
2 YEAR CAGR
16.39%
5 YEAR CAGR
23.31%
10 YEAR CAGR